ReP USP - Resultado da busca

Artigo de periodico
DNA methylation in stress and depression:: from biomarker to therapeutics (2021)
Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Wegener, Sâmia Regiane Lourenço Joca
Source: Acta Neuropsychiatrica. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, BIOMARCADORES, CÉREBRO, METILAÇÃO DE DNA, DEPRESSÃO, REGULAÇÃO GÊNICA, ESTRESSE PSICOLÓGICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Amanda Juliana e GUIMARÃES, Francisco Silveira e WEGENER, Sâmia Regiane Lourenço Joca. DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, v. 33, n. 5, p. 217-241, 2021Tradução . . Disponível em: https://doi.org/10.1017/neu.2021.18. Acesso em: 16 nov. 2024.
APA
Sales, A. J., Guimarães, F. S., & Wegener, S. R. L. J. (2021). DNA methylation in stress and depression:: from biomarker to therapeutics. Acta Neuropsychiatrica, 33( 5), 217-241. doi:10.1017/neu.2021.18
NLM
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/neu.2021.18
Vancouver
Sales AJ, Guimarães FS, Wegener SRLJ. DNA methylation in stress and depression:: from biomarker to therapeutics [Internet]. Acta Neuropsychiatrica. 2021 ; 33( 5): 217-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/neu.2021.18
Artigo de periodico
Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects (2021)
Sartim, Ariandra Guerini; Marques, J.; Silveira, Kennia Moura; Nunes, Pedro Henrique Gobira; Guimarães, Francisco Silveira ; Wegener, G.; Wegener, Sâmia Regiane Lourenço Joca
Source: Neuropharmacology. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, COMPORTAMENTO ANIMAL, CANABINOIDES, DEPRESSÃO, HIPOCAMPO, ATIVIDADE MOTORA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTIM, Ariandra Guerini et al. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, v. 195, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108679. Acesso em: 16 nov. 2024.
APA
Sartim, A. G., Marques, J., Silveira, K. M., Nunes, P. H. G., Guimarães, F. S., Wegener, G., & Wegener, S. R. L. J. (2021). Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology, 195. doi:10.1016/j.neuropharm.2021.108679
NLM
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Vancouver
Sartim AG, Marques J, Silveira KM, Nunes PHG, Guimarães FS, Wegener G, Wegener SRLJ. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects [Internet]. Neuropharmacology. 2021 ; 195[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108679
Parte de monografia/livro
Putative effects of cannabidiol in depression and synaptic plasticity (2021)
Wegener, Sâmia Regiane Lourenço Joca ; Silote, Gabriela Pandini; Sartim, Ariandra Guerini; Sales, Amanda Juliana; Guimarães, Francisco Silveira ; Wegener, Gregers
Source: The neuroscience of depression: features, diagnosis, and treatment. Unidades: FCFRP, FMRP
Subjects: CANABINOIDES, DEPRESSÃO, ANSIEDADE, ANTIDEPRESSIVOS, NEUROCIÊNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEGENER, Sâmia Regiane Lourenço Joca et al. Putative effects of cannabidiol in depression and synaptic plasticity. The neuroscience of depression: features, diagnosis, and treatment. Tradução . London: Academic Press, 2021. p. 592 . Disponível em: https://doi.org/10.1016/B978-0-12-817933-8.00052-9. Acesso em: 16 nov. 2024.
APA
Wegener, S. R. L. J., Silote, G. P., Sartim, A. G., Sales, A. J., Guimarães, F. S., & Wegener, G. (2021). Putative effects of cannabidiol in depression and synaptic plasticity. In The neuroscience of depression: features, diagnosis, and treatment (p. 592 ). London: Academic Press. doi:10.1016/B978-0-12-817933-8.00052-9
NLM
Wegener SRLJ, Silote GP, Sartim AG, Sales AJ, Guimarães FS, Wegener G. Putative effects of cannabidiol in depression and synaptic plasticity [Internet]. In: The neuroscience of depression: features, diagnosis, and treatment. London: Academic Press; 2021. p. 592 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/B978-0-12-817933-8.00052-9
Vancouver
Wegener SRLJ, Silote GP, Sartim AG, Sales AJ, Guimarães FS, Wegener G. Putative effects of cannabidiol in depression and synaptic plasticity [Internet]. In: The neuroscience of depression: features, diagnosis, and treatment. London: Academic Press; 2021. p. 592 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/B978-0-12-817933-8.00052-9
Artigo de periodico
Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors (2021)
Arcaro, Carlos Alberto; Assis, Renata Pires; Oliveira, Juliana Oriel; Zanon, Neusa Maria; Paula-Gomes, Silvia; Navegantes, Luiz Carlos Carvalho ; Kettelhut, Isis do Carmo ; Brunetti, Iguatemy Lourenço; Baviera, Amanda Martins
Source: Life Sciences. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, MÚSCULO ESQUELÉTICO, METABOLISMO DE PROTEÍNA, PROTEÍNAS DO TECIDO NERVOSO, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARCARO, Carlos Alberto et al. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, v. 278, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2021.119563. Acesso em: 16 nov. 2024.
APA
Arcaro, C. A., Assis, R. P., Oliveira, J. O., Zanon, N. M., Paula-Gomes, S., Navegantes, L. C. C., et al. (2021). Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors. Life Sciences, 278, 1-12. doi:10.1016/j.lfs.2021.119563
NLM
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563
Vancouver
Arcaro CA, Assis RP, Oliveira JO, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut I do C, Brunetti IL, Baviera AM. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors [Internet]. Life Sciences. 2021 ; 278 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.lfs.2021.119563
Artigo de periodico
Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model (2021)
Pinto, Leonardo Santos Ribeiro; Bapat, Priya; Moreira, Fernanda de Lima; Lubetsky, Angelika; Cavalli, Ricardo de Carvalho; Berger, Howard; Lanchote, Vera Lucia ; Koren, Gideon
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ANTAGONISTAS, FARMACOTERAPIA, ANTIDEPRESSIVOS, PLACENTA, COMPLICAÇÕES NA GRAVIDEZ, ANTI-HISTAMÍNICOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, v. 38, n. 4, p. 647-655, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11095-021-03035-7. Acesso em: 16 nov. 2024.
APA
Pinto, L. S. R., Bapat, P., Moreira, F. de L., Lubetsky, A., Cavalli, R. de C., Berger, H., et al. (2021). Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, 38( 4), 647-655. doi:10.1007/s11095-021-03035-7
NLM
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Vancouver
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Tese (Doutorado)
Behavioural and molecular effects induced by Cannabidiol in animal models of depression (2021)
Silote, Gabriela Pandini ; Wegener, Sâmia Regiane Lourenço Joca (Orientador)
Unidade: FCFRP
Subjects: CANABINOIDES, EXPRESSÃO GÊNICA, RATOS, DEPRESSÃO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILOTE, Gabriela Pandini. Behavioural and molecular effects induced by Cannabidiol in animal models of depression. 2021. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/60/60138/tde-29092021-060118/. Acesso em: 16 nov. 2024.
APA
Silote, G. P. (2021). Behavioural and molecular effects induced by Cannabidiol in animal models of depression (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de https://www.teses.usp.br/teses/disponiveis/60/60138/tde-29092021-060118/
NLM
Silote GP. Behavioural and molecular effects induced by Cannabidiol in animal models of depression [Internet]. 2021 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60138/tde-29092021-060118/
Vancouver
Silote GP. Behavioural and molecular effects induced by Cannabidiol in animal models of depression [Internet]. 2021 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/60/60138/tde-29092021-060118/
Artigo de periodico
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action (2021)
Chaves, Yane Costa; Genaro, Karina; Crippa, José Alexandre de Souza ; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Metabolic Brain Disease. Unidade: FMRP
Subjects: ANSIOLÍTICOS, ANTIDEPRESSIVOS, CANABINOIDES, DIABETES MELLITUS, FARMACOTERAPIA, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, v. 36, n. 4, p. 639-652, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11011-020-00667-3. Acesso em: 16 nov. 2024.
APA
Chaves, Y. C., Genaro, K., Crippa, J. A. de S., Cunha, J. M. da, & Zanoveli, J. M. (2021). Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, 36( 4), 639-652. doi:10.1007/s11011-020-00667-3
NLM
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Vancouver
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
Artigo de periodico
Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol (2021)
Silote, Gabriela Pandini ; Gatto, Michelle C.; Eskelund, Amanda; Guimarães, Francisco Silveira ; Wegener, Gregers; Joca, Sâmia Regiane Lourenço
Source: Pharmaceuticals. Unidades: FMRP, FCFRP
Subjects: CANNABIS, ANTIDEPRESSIVOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILOTE, Gabriela Pandini et al. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol. Pharmaceuticals, v. 14, n. 12, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14121269. Acesso em: 16 nov. 2024.
APA
Silote, G. P., Gatto, M. C., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2021). Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol. Pharmaceuticals, 14( 12), 1-19. doi:10.3390/ph14121269
NLM
Silote GP, Gatto MC, Eskelund A, Guimarães FS, Wegener G, Joca SRL. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol [Internet]. Pharmaceuticals. 2021 ; 14( 12): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph14121269
Vancouver
Silote GP, Gatto MC, Eskelund A, Guimarães FS, Wegener G, Joca SRL. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol [Internet]. Pharmaceuticals. 2021 ; 14( 12): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph14121269
Artigo de periodico
Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment (2021)
Ferreira, Frederico Rogério; Cupido, Alexander; Catalin, Bogdan; Silva Junior, Wilson Araújo da ; Kirchhoff, Frank; Del Bel, Elaine Aparecida ; Guimarães, Francisco Silveira
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: ASTRÓCITOS, CALMODULINA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Frederico Rogério et al. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, v. 39, n. 3, p. 860-871, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12640-021-00334-0. Acesso em: 16 nov. 2024.
APA
Ferreira, F. R., Cupido, A., Catalin, B., Silva Junior, W. A. da, Kirchhoff, F., Del Bel, E. A., & Guimarães, F. S. (2021). Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment. Neurotoxicity Research, 39( 3), 860-871. doi:10.1007/s12640-021-00334-0
NLM
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Vancouver
Ferreira FR, Cupido A, Catalin B, Silva Junior WA da, Kirchhoff F, Del Bel EA, Guimarães FS. Astrocyte intracellular Ca2+and TrkB signaling in the hippocampus could be involved in the beneficial behavioral effects of antidepressant treatment [Internet]. Neurotoxicity Research. 2021 ; 39( 3): 860-871.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s12640-021-00334-0
Artigo de periodico
Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats (2021)
Hernandes, Paloma Molina; Batistela, Matheus Fitipaldi; Vilela-Costa, Heloísa Helena; Sant’Ana, Ana Beatriz; Kumpel, Vinicíus Dias; Tirapelle, Mariane Cariati; Bom, Ariela de Oliveira Pedro; Andrade, Telma Gonçalves Carneiro Spera de; Zangrossi Junior, Hélio
Source: Behavioural Brain Research. Unidades: FMRP, FCFRP
Subjects: SEROTONINA, ANSIEDADE, PÂNICO, RECEPTORES, HIPOCAMPO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDES, Paloma Molina et al. Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats. Behavioural Brain Research, v. 408, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113296. Acesso em: 16 nov. 2024.
APA
Hernandes, P. M., Batistela, M. F., Vilela-Costa, H. H., Sant’Ana, A. B., Kumpel, V. D., Tirapelle, M. C., et al. (2021). Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats. Behavioural Brain Research, 408. doi:10.1016/j.bbr.2021.113296
NLM
Hernandes PM, Batistela MF, Vilela-Costa HH, Sant’Ana AB, Kumpel VD, Tirapelle MC, Bom A de OP, Andrade TGCS de, Zangrossi Junior H. Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats [Internet]. Behavioural Brain Research. 2021 ; 408[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbr.2021.113296
Vancouver
Hernandes PM, Batistela MF, Vilela-Costa HH, Sant’Ana AB, Kumpel VD, Tirapelle MC, Bom A de OP, Andrade TGCS de, Zangrossi Junior H. Role of 5-HT1A receptors in the ventral hippocampus in the regulation of anxiety- and panic-related defensive behaviors in rats [Internet]. Behavioural Brain Research. 2021 ; 408[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbr.2021.113296
Artigo de periodico
Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray (2021)
Batistela, Matheus Fitipaldi; Vilela-Costa, Heloisa Helena; Frias, Alana Tercino ; Hernandes, Paloma Molina; Lovick, Thelma A.; Zangrossi Junior, Hélio
Source: Journal of Psychopharmacology. Unidade: FMRP
Subjects: COMPORTAMENTO ANIMAL, ANTIDEPRESSIVOS, ANÓXIA, CICLO MENSTRUAL, PÂNICO, TRANSTORNO DO PÂNICO, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTELA, Matheus Fitipaldi et al. Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray. Journal of Psychopharmacology, v. 35, n. 12, p. 1523-1535, 2021Tradução . . Disponível em: https://doi.org/10.1177/02698811211058986. Acesso em: 16 nov. 2024.
APA
Batistela, M. F., Vilela-Costa, H. H., Frias, A. T., Hernandes, P. M., Lovick, T. A., & Zangrossi Junior, H. (2021). Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray. Journal of Psychopharmacology, 35( 12), 1523-1535. doi:10.1177/02698811211058986
NLM
Batistela MF, Vilela-Costa HH, Frias AT, Hernandes PM, Lovick TA, Zangrossi Junior H. Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray [Internet]. Journal of Psychopharmacology. 2021 ; 35( 12): 1523-1535.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/02698811211058986
Vancouver
Batistela MF, Vilela-Costa HH, Frias AT, Hernandes PM, Lovick TA, Zangrossi Junior H. Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray [Internet]. Journal of Psychopharmacology. 2021 ; 35( 12): 1523-1535.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/02698811211058986
Trabalho de evento-resumo
Crystal engineering applied to enantiomeric resolution of racemic fluoxetine (2021)
Ellena, Javier
Source: Book of abstracts. Conference titles: Crystal Forms @Bologna. Unidade: IFSC
Subjects: CRISTALOGRAFIA, PLANEJAMENTO DE FÁRMACOS, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELLENA, Javier. Crystal engineering applied to enantiomeric resolution of racemic fluoxetine. 2021, Anais.. Bologna: PolyCrystalLine SpA, 2021. Disponível em: http://www.polycrystalline.it/filemanager/Pdf-CF-BO21/Book_of_abstracts.pdf. Acesso em: 16 nov. 2024.
APA
Ellena, J. (2021). Crystal engineering applied to enantiomeric resolution of racemic fluoxetine. In Book of abstracts. Bologna: PolyCrystalLine SpA. Recuperado de http://www.polycrystalline.it/filemanager/Pdf-CF-BO21/Book_of_abstracts.pdf
NLM
Ellena J. Crystal engineering applied to enantiomeric resolution of racemic fluoxetine [Internet]. Book of abstracts. 2021 ;[citado 2024 nov. 16 ] Available from: http://www.polycrystalline.it/filemanager/Pdf-CF-BO21/Book_of_abstracts.pdf
Vancouver
Ellena J. Crystal engineering applied to enantiomeric resolution of racemic fluoxetine [Internet]. Book of abstracts. 2021 ;[citado 2024 nov. 16 ] Available from: http://www.polycrystalline.it/filemanager/Pdf-CF-BO21/Book_of_abstracts.pdf
Artigo de periodico
A partial least squares and artifcial neural network study for a series of arylpiperazines as antidepressant agents (2021)
Santos, Genisson R.; Chiari, Laise Pellegrini Alencar ; Silva, Aldineia P. da; Lipinski, Célio Fernando ; Oliveira, Aline A.; Honório, Káthia Maria ; Sousa, Alexsandro Gama de; Silva, Alberico Borges Ferreira da
Source: Journal of Molecular Modeling: computational chemistry - life science - advanced materials - new methods. Unidades: EACH, IQSC
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Genisson R. et al. A partial least squares and artifcial neural network study for a series of arylpiperazines as antidepressant agents. Journal of Molecular Modeling: computational chemistry - life science - advanced materials - new methods, p. 297, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00894-021-04906-x. Acesso em: 16 nov. 2024.
APA
Santos, G. R., Chiari, L. P. A., Silva, A. P. da, Lipinski, C. F., Oliveira, A. A., Honório, K. M., et al. (2021). A partial least squares and artifcial neural network study for a series of arylpiperazines as antidepressant agents. Journal of Molecular Modeling: computational chemistry - life science - advanced materials - new methods, 297. doi:10.1007/s00894-021-04906-x
NLM
Santos GR, Chiari LPA, Silva AP da, Lipinski CF, Oliveira AA, Honório KM, Sousa AG de, Silva ABF da. A partial least squares and artifcial neural network study for a series of arylpiperazines as antidepressant agents [Internet]. Journal of Molecular Modeling: computational chemistry - life science - advanced materials - new methods. 2021 ;297.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00894-021-04906-x
Vancouver
Santos GR, Chiari LPA, Silva AP da, Lipinski CF, Oliveira AA, Honório KM, Sousa AG de, Silva ABF da. A partial least squares and artifcial neural network study for a series of arylpiperazines as antidepressant agents [Internet]. Journal of Molecular Modeling: computational chemistry - life science - advanced materials - new methods. 2021 ;297.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00894-021-04906-x
Artigo de periodico
Is ionizing radiation effective in removing pharmaceuticals from wastewater? (2021)
Tominaga, Flávio Kioyoshi ; Silva Thalita Tieko; Boiani, Nathalia Fonseca; Jesus, Juliana Mendonça Silva de ; Teixeira, Antonio Carlos S. C. ; Borrely, Sueli Ivone
Source: Environmental Science and Pollution Research. Unidades: EP, IPEN
Subjects: ANTIDEPRESSIVOS, ANTI-INFLAMATÓRIOS, RADIAÇÃO IONIZANTE, TRATAMENTO DE ÁGUAS RESIDUÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMINAGA, Flávio Kioyoshi et al. Is ionizing radiation effective in removing pharmaceuticals from wastewater?. Environmental Science and Pollution Research, v. 28, p. 23975–23983, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11356-020-11718-8. Acesso em: 16 nov. 2024.
APA
Tominaga, F. K., Silva Thalita Tieko,, Boiani, N. F., Jesus, J. M. S. de, Teixeira, A. C. S. C., & Borrely, S. I. (2021). Is ionizing radiation effective in removing pharmaceuticals from wastewater? Environmental Science and Pollution Research, 28, 23975–23983. doi:10.1007/s11356-020-11718-8
NLM
Tominaga FK, Silva Thalita Tieko, Boiani NF, Jesus JMS de, Teixeira ACSC, Borrely SI. Is ionizing radiation effective in removing pharmaceuticals from wastewater? [Internet]. Environmental Science and Pollution Research. 2021 ; 28 23975–23983.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11356-020-11718-8
Vancouver
Tominaga FK, Silva Thalita Tieko, Boiani NF, Jesus JMS de, Teixeira ACSC, Borrely SI. Is ionizing radiation effective in removing pharmaceuticals from wastewater? [Internet]. Environmental Science and Pollution Research. 2021 ; 28 23975–23983.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11356-020-11718-8
Tese (Doutorado)
Estimulação elétrica por corrente contínua no tratamento do transtorno obsessivo-compulsivo: um ensaio clínico duplo-cego, randomizado e controlado com placebo (2021)
Silva, Renata de Melo Felipe da; Shavitt, Roseli Gedanke (Orientador) ; Brunoni, Andre Russowsky (coorient)
Unidade: FM
Subjects: ANTIDEPRESSIVOS, ENSAIO CLÍNICO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Renata de Melo Felipe da. Estimulação elétrica por corrente contínua no tratamento do transtorno obsessivo-compulsivo: um ensaio clínico duplo-cego, randomizado e controlado com placebo. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/5/5142/tde-28092021-113531/. Acesso em: 16 nov. 2024.
APA
Silva, R. de M. F. da. (2021). Estimulação elétrica por corrente contínua no tratamento do transtorno obsessivo-compulsivo: um ensaio clínico duplo-cego, randomizado e controlado com placebo (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/5/5142/tde-28092021-113531/
NLM
Silva R de MF da. Estimulação elétrica por corrente contínua no tratamento do transtorno obsessivo-compulsivo: um ensaio clínico duplo-cego, randomizado e controlado com placebo [Internet]. 2021 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/5/5142/tde-28092021-113531/
Vancouver
Silva R de MF da. Estimulação elétrica por corrente contínua no tratamento do transtorno obsessivo-compulsivo: um ensaio clínico duplo-cego, randomizado e controlado com placebo [Internet]. 2021 ;[citado 2024 nov. 16 ] Available from: https://www.teses.usp.br/teses/disponiveis/5/5142/tde-28092021-113531/
Artigo de periodico
Factors associated with use of medications for anxiety and depression in pharmacy students in Brazil (2021)
Amaral, Carolina Maranhão Meneghel; Carvalho, Renata Cunha; Vieira, Márcio Eduardo Bergamini ; Aguiar, Patrícia Melo
Source: American Journal of Pharmaceutical Education. Unidades: HU, FCF
Subjects: ANSIEDADE, DEPRESSÃO, ESTUDANTES UNIVERSITÁRIOS, FARMÁCIA, ANTIDEPRESSIVOS, FÁRMACOS PSICOTRÓPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Carolina Maranhão Meneghel et al. Factors associated with use of medications for anxiety and depression in pharmacy students in Brazil. American Journal of Pharmaceutical Education, v. 85, n. 6, p. 1-10 art. 8285, 2021Tradução . . Disponível em: https://doi.org/10.5688/ajpe8285. Acesso em: 16 nov. 2024.
APA
Amaral, C. M. M., Carvalho, R. C., Vieira, M. E. B., & Aguiar, P. M. (2021). Factors associated with use of medications for anxiety and depression in pharmacy students in Brazil. American Journal of Pharmaceutical Education, 85( 6), 1-10 art. 8285. doi:10.5688/ajpe8285
NLM
Amaral CMM, Carvalho RC, Vieira MEB, Aguiar PM. Factors associated with use of medications for anxiety and depression in pharmacy students in Brazil [Internet]. American Journal of Pharmaceutical Education. 2021 ; 85( 6): 1-10 art. 8285.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5688/ajpe8285
Vancouver
Amaral CMM, Carvalho RC, Vieira MEB, Aguiar PM. Factors associated with use of medications for anxiety and depression in pharmacy students in Brazil [Internet]. American Journal of Pharmaceutical Education. 2021 ; 85( 6): 1-10 art. 8285.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5688/ajpe8285
Artigo de periodico-divulgacao
Depressão solidária (2021)
Dunker, Christian Ingo Lenz
Source: Socialismo e Liberdade. Unidade: IP
Subjects: DEPRESSÃO, NEOLIBERALISMO, ANTIDEPRESSIVOS, CONFLITO, AGRESSIVIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUNKER, Christian Ingo Lenz. Depressão solidária. Socialismo e Liberdade. Rio de Janeiro: Instituto de Psicologia, Universidade de São Paulo. Disponível em: http://www.laurocampos.org.br/wp-content/uploads/2021/06/2021-N32-Revista-Socialismo-e-Liberdade.pdf. Acesso em: 16 nov. 2024. , 2021
APA
Dunker, C. I. L. (2021). Depressão solidária. Socialismo e Liberdade. Rio de Janeiro: Instituto de Psicologia, Universidade de São Paulo. Recuperado de http://www.laurocampos.org.br/wp-content/uploads/2021/06/2021-N32-Revista-Socialismo-e-Liberdade.pdf
NLM
Dunker CIL. Depressão solidária [Internet]. Socialismo e Liberdade. 2021 ;( 32): 46-53.[citado 2024 nov. 16 ] Available from: http://www.laurocampos.org.br/wp-content/uploads/2021/06/2021-N32-Revista-Socialismo-e-Liberdade.pdf
Vancouver
Dunker CIL. Depressão solidária [Internet]. Socialismo e Liberdade. 2021 ;( 32): 46-53.[citado 2024 nov. 16 ] Available from: http://www.laurocampos.org.br/wp-content/uploads/2021/06/2021-N32-Revista-Socialismo-e-Liberdade.pdf
Artigo de periodico
Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats (2021)
Vilela-Costa, Heloisa Helena; Maraschin, Jhonatan Christian; Casarotto, Plinio C.; Sant’Ana, Ana Beatriz; Bortoli, Valquiria C. de; Vicente, Maria Adrielle; Campos, Alline Cristina; Guimarães, Francisco Silveira ; Zangrossi Junior, Hélio
Source: Behavioural Brain Research. Unidade: FMRP
Subjects: PÂNICO, ANSIEDADE, SEROTONINA, DORSO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILELA-COSTA, Heloisa Helena et al. Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats. Behavioural Brain Research, v. 404, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2021.113159. Acesso em: 16 nov. 2024.
APA
Vilela-Costa, H. H., Maraschin, J. C., Casarotto, P. C., Sant’Ana, A. B., Bortoli, V. C. de, Vicente, M. A., et al. (2021). Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats. Behavioural Brain Research, 404. doi:10.1016/j.bbr.2021.113159
NLM
Vilela-Costa HH, Maraschin JC, Casarotto PC, Sant’Ana AB, Bortoli VC de, Vicente MA, Campos AC, Guimarães FS, Zangrossi Junior H. Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats [Internet]. Behavioural Brain Research. 2021 ; 404[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbr.2021.113159
Vancouver
Vilela-Costa HH, Maraschin JC, Casarotto PC, Sant’Ana AB, Bortoli VC de, Vicente MA, Campos AC, Guimarães FS, Zangrossi Junior H. Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats [Internet]. Behavioural Brain Research. 2021 ; 404[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbr.2021.113159
Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 16 nov. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial (2021)
Guimarães, Mara C.; Guimarães, Tiago M.; Hallak, Jaime Eduardo Cecilio ; Abrão, João; Machado-de-Sousa, João Paulo
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, FARMACOTERAPIA, MÉTODO DUPLO-CEGO, ÓXIDO NÍTRICO, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Mara C. et al. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial. Brazilian Journal of Psychiatry, v. 43, n. 5, p. 484-493, 2021Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2020-1543. Acesso em: 16 nov. 2024.
APA
Guimarães, M. C., Guimarães, T. M., Hallak, J. E. C., Abrão, J., & Machado-de-Sousa, J. P. (2021). Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial. Brazilian Journal of Psychiatry, 43( 5), 484-493. doi:10.1590/1516-4446-2020-1543
NLM
Guimarães MC, Guimarães TM, Hallak JEC, Abrão J, Machado-de-Sousa JP. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5): 484-493.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/1516-4446-2020-1543
Vancouver
Guimarães MC, Guimarães TM, Hallak JEC, Abrão J, Machado-de-Sousa JP. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial [Internet]. Brazilian Journal of Psychiatry. 2021 ; 43( 5): 484-493.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/1516-4446-2020-1543

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration